ABSTRACT
Transcellular Ca
2ϩ transport is a highly energyconsuming process because Ca 2ϩ efflux has to be accomplished against an ϳ10,000-fold concentration gradient and an ϳ40 -60 mV membrane potential difference. Ca 2ϩ influx, in contrast, follows this electrochemical gradient and must be tightly regulated to avoid toxic Ca 2ϩ overload. TRPV5 and TRPV6 are highly selective for Ca 2ϩ , and their vitamin D-regulated expression in Ca 2ϩ -transporting epithelia (e.g., placental tissues and epithelial cells of the intestine and kidney) and in exocrine tissues such as pancreatic acinar and salivary gland cells (TRPV6) make them candidates for selective Ca 2ϩ entry (1, 2) . In expression systems they are constitutively active at low intracellular Ca 2ϩ concentrations (3) (4) (5) . Ca 2ϩ -dependent negative feedback regulation has been studied in detail for both channels (6, 7) . TRPV6 shows both a rapid, Ca 2ϩ -dependent but calmodulin-independent regulation with involvement of the first intracellular loop (8, 9) and a slower calmodulin-dependent regulation that involves binding of calmodulin to the distal C-terminal region of the protein (10, 11) . Depletion of PIP 2 also interferes with Ca 2ϩ -dependent inactivation (12) and with permeation block by Mg 2ϩ , as shown for TRPV5 (13) . But are these the signals that keep channels open if more Ca 2ϩ uptake is required? Which regulatory pathways close the channels when sufficient Ca 2ϩ has been transferred?
Many ion channels and transporters are regulated by ATP-dependent mechanisms (14 -20) , but the mechanism and binding sites for Ca 2ϩ channels are unknown. For the capsaicin receptor TRPV1 it has recently been shown that binding of ATP within its N-terminal ankyrin repeat domains (ARDs) can prevent capsaicininduced tachyphylaxis. Here binding of ATP competes with binding of calmodulin (21) . Although TRPV6 contains a similar number and a related structure of ARDs as TRPV1, it neither binds calmodulin within its ARDs nor is the ATP binding pocket of TRPV1 conserved (21, 22) .
TRPV6 also exhibits a highly unusual coupled polymorphism within the human population (5): although the ancestral allele (TRPV6a: R157, V378, T681) is predominant among African populations, the derived allele (TRPV6b: C157, M378, and M681) is predominant in all other tested population groups, suggesting that this haplotype conferred a temporally or geographically selective advantage (23) . The reason for this selection has remained elusive, and no obvious differences in ion channel properties have been found (24) . TRPV6 expression correlates with the invasiveness of certain cancers such as prostate cancer and may serve as a prognostic marker for its outcome (25) . Whether the increased incidence of prostate cancer among African Americans (26) correlates with the TRPV6 polymorphism is unknown. To understand how channels are regulated by the metabolic status, we investigated the influence and the mechanism of ATP regulation. Because ATP is expected to fuel protein kinases and because the 2 alleles differ in the number of potential PKC phosphorylation sites, we also focused on the regulation by protein kinases.
MATERIALS AND METHODS

Cell culture
HEK293 cells (CRL-1573; American Type Culture Collection, Manassas, VA, USA) and TRPV6 stable cell lines were maintained in a 37°C, 5%CO 2 humidified incubator in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal calf serum and 4 mM l-glutamine and supplemented with 200 U/ml penicillin-G-sodium and 100 g/ml streptomycin or hygromycin-b (Invitrogen, Carlsbad, CA, USA), respectively. Cells were passaged by treatment with trypsin. Stable cell lines were created from TRPV6a-or -b-expressing vector (pcDNA5/FRT) transfected into Flp-In™-293 cells (Invitrogen) using Superfect Transfection-Reagent (Qiagen, Valencia, CA, USA). Transient transfections of constructs cloned into pCAGGS_IRES_EGFP plasmids were made with Fugene Transfection Reagent (Roche Diagnostics, Mannheim, Germany). Cells were trypsinized and seeded at low density after 24 h and recorded from after ϳ48 h.
Electrophysiology
TRPV6a (AJ243500) or TRPV6b (AJ243501) stable HEK293 (D11, C3) cells or transiently transfected wild-type or mutant constructs in pCAGGS-IRES-GFP were used for patch-clamp recordings. Recordings were performed at room temperature in the tight-seal whole-cell configuration using electrodes of 2-4 M⍀ resistance. Cell capacitance and access resistance were monitored before each voltage ramp, and measurements were discarded when ⌬ access resistance was Ͼ5 M⍀. Series resistance was compensated to 80%. Membrane currents were filtered at 1.5 kHz and digitized at a sampling rate of 5-10 kHz. Currents were recorded with an EPC-9 patch-clamp amplifier controlled by Pulse 8.3 software (HEKA Electronics, Lambrecht/Pfalz, Germany). Immediately after establishing whole-cell configuration, linear voltage ramps from Ϫ100 to ϩ100 mV within 100 ms were applied every 10 s from a holding potential of ϩ70 mV for 10 or 20 min as indicated. Currents at Ϫ80 mV ramp potential were divided by cell capacitance, normalized (CD/CD max , where CDϭcurrent density), and plotted against time. The pipette solution contained the following (in mM): 140 cesium aspartate, 10 EGTA, 10 NaCl, 10 HEPES, and 16 M MgCl 2 or 1 mM MgCl 2 with 6 mM Na 2 ATP (pH 7.2 with CsOH). The resulting free Mg 2ϩ concentration of 11 M was kept constant for the different concentrations of ATP or other nucleotides by adjusting total [Mg 2ϩ ] using CaBuf software (ftp://ftp.cc.kuleuven. ac.be/pub/droogmans/cabuf.zip). The bath solution contained the following (in mM): 115 tetraethylammonium chloride, 10 CsCl, 2.8 KCl, 2 MgCl 2 , 30 CaCl 2 , 10 glucose, and 20 HEPES (pH 7.4 with NaOH). ATP concentration-response curves were fitted by Eq. 1: (1) Statistical analysis was performed using an unpaired, 2-tailed Student's t test. Values of P Ͻ 0.05 were considered significant.
Fluorescence-based Ca 2؉ imaging
Imaging of free intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) was performed using an Olympus IX 70 inverted microscope (Olympus Deutschland, Hamburg, Germany) equipped with an ϫ20 (UApo/ 340, N.A. 0.75) objective, a Polychrome V Monochromator, and a charge-coupled device camera (TILL Imago; TILL Photonics, Gräfelfing, Germany). HEK cells were loaded with 1 M Fura-2/AM in DMEM growth medium at 37°C for 15 min in a dark chamber. Images were analyzed using TILL Vision software. Bath solutions contained (in mM): 150 NaCl, 2.8 KCl, 1 MgCl 2, 1 CaCl 2 , 20 glucose, and 10 HEPES (pH 7.4 with NaOH) or with 135 NaCl and 10 CaCl 2 . In the ATP depletion medium NaCl was reduced to 140 mM, glucose was substituted by 20 mM deoxyglucose, and 10 mM sodium azide (NaN 3 ) was added. The absolute intracellular Ca 2ϩ -concentration was calculated as described by Grynkiewicz et al. (27) . 
Fluorescence
Site-directed mutagenesis
Quickchange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) was used to introduce the desired mutations (namely, R153Q/R154P and R606Q) and to mutate the potential phosphorylation sites identified by the prosite software (http://www.expasy.ch/prosite) or the NetPhosK (http://www.cbs.dtu.dk/services/NetPhosK/) by replacing the serine or threonine codons at the specified sites with alanine codons (S144A, T150A, T298A, T299A, S318A, T688A, T702A). The mutated fragments were confirmed by double-stranded sequencing. Unless otherwise noted, mutations were done in the hTRPV6b background.
Cloning and expression of His-tagged proteins
The sequences coding for different fragments of the human TRPV6 N-and C-termini were PCR amplified from hTRPV6b cDNA and subcloned into the BamHI or XhoI site of pET19b vector (10 N-term HIS). The fusion protein covering aa 1-117 was made from mouse TRPV6. Protein expression was carried out in transformed Escherichia coli BL21 strains. Overnight cultures were diluted 1:20, grown until an OD 600 of 0.5, and protein production was induced with 100 M of IPTG for 4 h at 30°C. Cells were pelleted by centrifugation at 6000 g for 15 min, and pellets were initially resuspended in 5 mM imidazole, 500 mM NaCl, and 20 mM Tris (pH 7.9). Lysates were sonicated 3 ϫ 30 s and centrifuged at 13,000 g for 20 min, and pellets were resuspended in the above buffer with a repeat of sonication and centrifugation. The final resuspension buffer also contained 6 M urea (BBU). Lysates were then incubated with gentle rotation at 4°C for 1 h and pottered with a Dounce homogenizer. Finally, lysates were ultracentrifuged at 24,000 g for 25 min at 4°C, and supernatants were incubated overnight with Ni-NTA beads (Qiagen). Columns were washed once with BBU, then with BBU containing 15 mM imidazole. Proteins were eluted with BBU with 1 M imidazole. The integrity and size of the purified proteins were checked by Coomassie-stained PAGE gels, and protein concentration was determined by BCA (Pierce, Rockford, IL, USA). For native protein expression, ARD and CT (633-725) were cloned into a modified pET21b vector (28) , and bacteria were induced at an OD 600 of 0.5 with 75 M IPTG for 16 h at 25°C. Pellets were resuspended in 20 mM Tris-HCL (pH 8.0), 300 mM NaCl, 20 mM Imidazole, 1 mM PMSF, 0.1% Triton-X-100, 0.2 mg/ml lysozyme, 50 g/ml RNase, and 25 g/ml DNase and treated as above. The cleared (20 min at 30,000 g) lysates were incubated with Ni-NTA beads for 2 h at 4°C and washed with 20 mM Tris-HCl (pH 8), 300 mM NaCl, and 20 mM imidazole. For elution, imidazole was increased to 200 mM.
ATP-agarose binding
Different His-tagged proteins (40 g) were diluted to 900 l with binding buffer: 10 mM Tris (pH 7.5), 50 mM NaCl, 1 mM DTT (no DTT for native proteins), and 0.15% w/v dodecyl-␤-D-maltopyranoside (see also ref. 21 ) with or without 6/15 mM ATP or adenosine, and incubated at 4°C first for 20 min, then with 75 l of prewashed 50% slurry of ATP-agarose (bound by a C 6 -spacer to C-8 of ATP; Sigma-Aldrich, St Louis, MO, USA) for 2 h with gentle rotation. Afterward, beads were sedimented, washed 4 times with 1 ml binding buffer, and resuspended in the corresponding loading buffer, depending on the type of gel and buffer used. Probes were denatured at 37°C for 30 min and separated by 15% SDS-PAGE or 10 -20% TRIS/Tricine PAGE. Samples were divided, and gels were either incubated with Coomassie-stain or used to blot the proteins to nitrocellulose or PVDF membranes followed by detection with our own affinity purified antibody against the His-tag. Binding experiments were repeated at least 3 times also with different batches of expressed protein.
RESULTS
ATP prevents rundown of TRPV6 Ca 2؉ currents
To investigate regulation of TRPV6 we recorded either from a stable TRPV6b-expressing cell line that was generated by targeted insertion or from HEK293 cells 48 h after transient transfection. Cells were subjected to voltage ramps at 0.1 Hz for 20 min, and currents were analyzed at Ϫ80 mV ramp potential. Figure 1A shows the development of inwardly rectifying Ca 2ϩ currents over time. In the absence of ATP, inward currents reach their maximum within the first 2 min, then decrease continuously to ϳ30% after 20 min. To quantitate this rundown, we defined the remaining current densities (%REM) at 20 min as percentage of maximum ( Figure 1D shows the mean inwardly rectifying current-voltage relationships for TRPV6b at different time points as indicated in Fig. 1A . To test whether rundown can be reduced by ATP, we included 6 mM Na 2 ATP in the recording pipette and clamped [Mg 2ϩ ] i to that of the control solution (11 M). Because [Mg 2ϩ ] i is below the IC 50 for Mg 2ϩ block of the pore (29), we can exclude confounding influences on pore properties. Inclusion of ATP led to altered kinetics of current development (Fig. 1A) : initial current densities were reduced to Ϫ16.3 Ϯ 3.4 pA/pF (nϭ15) compared to Ϫ39.7 Ϯ 15 pA/pF (nϭ11, PϾ0.5), and subsequent increments in current amplitude were also reduced, leading to current densities that did not decrease within the recording time (Fig.  1A) , thus resulting in ϳ100% REM after 20 min (Fig.  1B) . To test whether the initial reduction in current density was due to an effect of external perfusion of ATP while approaching the cell with the patch pipette, we recorded from cells with no ATP in the patch pipette but locally perfused ATP from a second pipette immediately before and after break-in. However, initial current densities were not reduced (Ϫ41.3Ϯ6.6 pA/pF, nϭ4), likely excluding activation of purinergic receptors as the cause of current reduction.
Mean IV relationships in the presence of ATP (Fig.  1E ) indicate that no other major ATP-induced conductances were observed with our recording conditions but revealed a minor decrease in the steepness of inward rectification. A shift in the same direction is seen in the absence of ATP when EGTA is replaced by BAPTA (data not shown), which may indicate a decrease in the Ca 2ϩ -dependent feedback mechanism when adding ATP to the EGTA pipette solution. To exclude the possibility that ATP is preventing rundown solely by increasing the fast calcium-buffering capacity of the pipette solution, we confirmed that ATP still had significant effects in the presence of 20 mM BAPTA (data not shown). Prevention of rundown by ATP has also been shown in Ca 2ϩ -free conditions (30) . The maximal current densities for TRPV6b after 20 min with ATP were Ϫ153 Ϯ 11 pA/pF, which were not different when compared to the maximal current densities without ATP (Ϫ160Ϯ27 pA/pF).
The effects of ATP on both kinetics of current development and on rundown were also seen with transient expression of TRPV6b. Rundown and t 1/2 were analyzed at 10 min recording time, as transiently expressing cells were less stable. Whereas in the absence of ATP the kinetics of current development, maximal current density, and the degree of rundown were comparable for transient vs. stable transfected cells (Supplemental Fig. S1A ), in the presence of ATP the slowdown of current development was also significant, but less pronounced than with stable TRPV6 expression (t 1/2 57Ϯ10 vs. 117Ϯ22 s for transient and stable expressed TRPV6b, respectively; Supplemental Fig. S1A, B) . Because oxidation has been shown to modulate binding of ATP to chloride channels (31), we used the fluorescent indicator DCF to test whether transient expression influences the redox state of the cells. Indeed, Supplemental Fig. S1C shows that transiently transfected cells showed higher levels of intracellular oxidants than stable cells. We thus investigated the influence of oxidants (H 2 O 2 ) on the time course of TRPV6 in the stable expression system. Supplemental Fig. S1D shows that increasing oxidative stress through addition of H 2 O 2 , probably by modifying reactive cysteines of TRPV6, leads to larger current increments in the presence of ATP and can thus explain the faster current development in cells transiently expressing TRPV6. However, even in the presence of a strong oxidant, ATP is still able to prevent rundown (Supplemental Fig. S1D ). For further analyses, we have focused on the effects of ATP on the percentage of rundown (%REM) and compared rundown at 20 min for stable and at 10 min for transient expression.
To mimic a more physiological condition, we tested the influence of ATP depletion (32) on Ca 2ϩ transients in unperturbed cells. Figure 1F shows that TRPV6 cells respond to a change in [Ca 2ϩ ] e with a transient increase in [Ca 2ϩ ] i . This transient increase can again be evoked after ϳ50 min (Fig. 1F, top panel) . However, when TRPV6 cells are ATP depleted, the second transient peak is absent (Fig. 1F, middle (Fig. 1F,  top panel) , which may be due to Ca (12) showed that hydrolysis of PIP 2 mediated Ca 2ϩ -induced inactivation of TRPV6 channels (12) . To test the potential involvement of PIP 2 in the ATP effect, we replaced ATP with 50 M diC 8 PIP 2, which was unable to prevent rundown in the absence of ATP ( Fig. 2A, B) . We also included a nonhydrolyzable ATP analog, AMP-PCP, in the pipette solution. This analog also prevented rundown and slowed current development ( Fig. 2A, B) . Because R599 was identified as a critical residue responsible for mediating PIP 2 -dependent channel activity in TRPV5 (34), we checked whether this highly conserved arginine mediates the ATP effect in TRPV6 (R599 in rbTRPV5ϭR606 in hTRPV6). We mutated R606 to Q and recorded the transiently expressed mutant in the presence and absence of ATP. Figure 2C , D shows that ATP is still able to prevent rundown in the mutant. Together with the evidence seen in Fig. 2A , the results suggest that ATP prevents rundown of TRPV6 in a PIP 2 -independent manner.
Nucleotide specificity
To further test the specificity of the ATP effect, we included different nucleotides in the pipette solution at 6 mM each. Figure 3A shows currents over time for some of the tested nucleotides, and Fig. 3B the percentage REM for all nucleotides tested. Although adenosine and cAMP were unable to prevent rundown, other phosphorylated nucleotides had intermediate effects,
with AMP being more potent than GTP and slightly more potent than UTP, which suggests that both nucleotide moiety and number of negatively charged phosphate groups are essential (Fig. 3A) . To test the dependence of rundown on the ATP concentration, we calculated the dose response relationship after recording currents with different free ATP concentrations, keeping free [Mg 2ϩ ] constant. Figure 3C shows sample traces of currents with 6, 304, and 609 M and 3.7 mM free ATP in the pipette solution. Data points were fitted with a sigmoidal dose-response function of variable slope, where %REM max is the maximal remaining current obtained after addition of 3.7 mM free ATP, EC 50 is the half-maximal concentration of free ATP, and n is the Hill slope. As shown in Fig. 3D , the mean EC 50 obtained from the graph was 378 M free ATP, and the Hill slope was 4.8. The EC 50 value obtained is one order of magnitude greater than that normally required for a kinase-mediated phosphorylation reaction (14) ; however, we also investigated the crosstalk between rundown and PKC-mediated phosphorylation.
Regulation by protein kinase C and identification of a functionally relevant ATP binding site
To measure TRPV6 currents in the presence of ATP and after activation of protein kinases, we incubated cells for 1 h with 500 nM PMA in serum-free medium and then recorded with PMA also present in the bath solution. Figure 4A shows that incubation with PMA was able to partially prevent the effects of ATP: Although ATP was included, current size increased much faster, reached maximal values within the first 2 min, and entered rundown (Fig. 4A, B) .
Because the ancestral polymorphic allele (TRPV6a) contains an additional potential PKC phosphorylation site (SPR 157 ) compared to SPC for TRPV6b, we also tested the effects of PMA treatment on TRPV6a and found a slightly more efficient prevention of the ATP effect (Fig. 4C, D) . In the absence of ATP, PMA treatment had little effect on rundown (Supplemental Fig. S2A, B) . The finding that the polymorphs differ slightly in the extent of the PMA effect may point toward S155 being involved in preventing the ATP effect. S155, as well as the joint first putative phosphorylation site S144, is located within the ARD in a loop between repeats 3 and 4 (see ref. 22 for structural information). We wondered whether phosphorylation can partially suppress the effects of ATP because of the charge screening effect of the phosphorylated (negative) moiety onto nearby positively charged side groups required for a direct interaction with the phosphate groups of ATP. If this were so, one would predict that this region also would contain residues important for ATP binding. Two positively charged arginine residues (R153/R154) are in proximity to the S144 phosphorylation site and adjacent to the polymorphic phosphorylation site S155 (Fig. 5A) . We thus mutated these residues (RR/QP) and recorded currents in the presence of 3.7 mM free ATP. As seen in Fig. 5B , D, ATP was now unable to prevent fast activation and rundown, confirming a functional importance of R153/R154. In addition, initial current densities [Ϫ29.8 pA/pF (ϪATP) vs. Ϫ29.4 pA/pF (ϩATP)] were identical, and maximal current densities were slightly larger than wild type. Reversion of the positive charges by mutating arginine into glutamate (RR/EE) resulted in an ϳ90% reduction in both initial and maximal current sizes, demonstrating that negative charges in this position critically affect ion channel function. Charge reversion also partially mimicked the current stabilizing effect of ATP by reducing the percentage REM in the absence of ATP to 70.5 compared to 45 for wild type (PϽ0.5). To further test that this region contains a functionally relevant ATP binding site, we included a peptide containing the sequence from aa 147 to 165 (see Fig. 5A ) together with ATP in the patch pipette. Figure 5C , E shows that the peptide was indeed able to compete with ATP and induce rundown. To test for direct binding of ATP to this protein region, we expressed and purified the protein fragment covering the ARD of wild-type and RR/QP mutants and tested their ability to be retained by ATP-agarose. Wild-type ARD is retained by ATP-agarose, and binding can be competed for by free ATP or UTP (data not shown), but not by adenosine (Fig. 5F ). In contrast, RR/QP-ARD showed a significant reduction in binding to ATP-agarose (Fig. 5F ). Together, these results suggest that the ARD 3-4 region with residues R153/154 mediate binding of ATP's negatively charged moieties and is responsible for its physiological effects. Phosphorylation at S144, and possibly at S155 in the case of TRPV6a, may prevent binding either by charge hindrance or by a conformational change.
If phosphorylation of TRPV6 mediates the PMA effect, we should be able to define functionally relevant phosphorylation sites by mutating the consensus site serine or threonine residues. The first site, S144, is solvent exposed (22) (Fig. 6A) , and S144A mutants were resistant to rundown in the presence of PMA (Fig. 6B, C) , confirming the hypothesis that ATP binding may be sterically hindered by phosphorylation at the ARD 3,4 linker region. The faster current development of S144A mutants (ϩATP) is partially due to transient expression (see Supplemental Fig. S1 ). Currents in the absence of ATP were identical to wild type (%REM; Fig. 6C ).
To test whether other PKC phosphorylation sites are also involved, we mutated single sites detected by the prosite algorithm (35) and investigated the effects of PMA. Figure 6A shows the relative location, and Fig. 6D -F shows average current densities over time for 3 additional mutants. Three other sites (T150A, S318A, and T702A) showed clear PMAinduced rundown (Fig. 6D, E, G) . Mutating the dual phosphorylation site T298A/T299A resulted in a weaker effect of PMA, but mutation of the C-terminal site T688A was as efficient as the S144A mutation in blocking the PMA effect (Fig. 6F, G) . All mutants displayed comparable rundown to wild type in the absence of added ATP (data not shown).We have also confirmed ATP-mediated prevention of rundown for mTRPV5 and for mTRPV6. Although other putative PKC sites are conserved between species, T688 is not a consensus site within mTRPV5, and PMA was unable to oppose the effects of ATP in mTRPV5 (see Supplemental Fig. S2C-F) . These results point toward a synergistic role of the C-terminal phosphorylation site in mediating the effect of PMA and raise the possibility that a C-terminal region could also be involved in binding of ATP.
Isozyme specificity
To address the specificity of the PMA effect, we incubated TRPV6b cells with an inactive analog of PMA, 4␣PDD. This inactive analog was unable to mimic the effects of PMA (Fig. 7A, B) , confirming a likely effect on activation of PKCs. We tried to block the effect of PMA by pretreatment with both BIS and Gö 6983, inhibitors of classical PKCs, and then added PMA for 1 h. Surprisingly, these inhibitors were unable to prevent the effect of PMA on current development (Fig. 7A, B) . Because neither BIS nor Gö 6983 has a defined IC 50 for the PKC ␤II isoform, we tested whether Ro-31-8322, with an IC 50 of 14 nM for PKC ␤II (36), was able to prevent PMA from counteracting the ATP effects. Figure 7A , B shows that Ro-31-8322 was indeed able to suppress the effects of PMA, suggesting that PMA exerts its effects through activation of PKC ␤II . Ro-31-8322 alone did not have effects on ATP-modulated TRPV6b currents in the absence of PMA (data not shown). One concern that remained was that long incubation times were necessary to see the effects of PMA, whereas translocation of cPKCs happens within minutes. However, HEK293 cells express only low levels of endogenous PKC ␤II protein (37); therefore, we overexpressed GFP-tagged PKC ␤II or GFP-tagged PKC ␣ and tested whether PMA was now able to exert its effects within minutes. Indeed, with expression of PKC ␤II , but not with overexpression of PKC ␣ , TRPV6 currents now showed PMA-induced rundown when added to the bath solution without preincubation (Fig.  7C, D) . Both PKC isoforms showed translocation to the plasma membrane after stimulation with PMA ( Fig. 7E and data not shown). To test if PKC ␤II expression is found in similar tissue types as TRPV6, we checked for its presence in human placenta cDNA (5) using isoform-specific PCR primers and were indeed able to amplify DNA of the correct size (Fig. 7F) .
ATP binding sites
To screen for additional ATP binding sites, we created fusion proteins (10xHIS at N-term) covering all intracellular protein domains and tested their ability to be retained by ATP-agarose. We found several additional potential binding regions within TRPV6: although the very N-terminal region of the protein containing ARD 1 and 2 (Supplemental Fig. S3B) was not retained by ATP-agarose, thus demonstrating that the HIS tag alone does not confer unspecific binding, the ARD region showed weak binding (see also Fig. 5 ). The N-terminal region between aa 267 and TM1 was also retained (Supplemental Fig. S3D ). Its sequence contains a basic KKR region as well as a potential PH domain and the dual phosphorylation site T298A/ T299A. The proximal region (aa 584-632) of the Cterminal domain containing the TRP motif showed binding that is not efficiently competed for by free ATP, and thus not as specific (Supplemental Fig. S3E) . However, the distal region (aa 633 to 725; CT) is well retained by ATP-agarose, and binding is effectively competed for by free ATP (Supplemental Fig. S3F ). We also checked retention of the ARD region of rat TRPV1 that has been shown to bind ATP (21) (Supplemental Fig. S3G ). Considering that T688 is a potential phosphorylation site preventing ATP binding (see Fig. 6F , G and Supplemental Fig. S2 ) and the finding that the C-terminal fusion protein encompassing T688 is well retained by ATP-agarose, we wanted to confirm binding to ATP agarose for ARD and CT proteins under native purification conditions. Because proteins containing the N-terminal 10xHIS tag could be solubilized only with urea, we constructed ARD and CT fusion proteins with a C-terminal 6xHIS Tag (Supplemental Fig. S3H ) and repeated binding experiments after native purification. ARD was retained by ATP-agarose with binding efficiencies of ϳ10% in several experiments (Coomassie and Western blot), and CT showed binding efficiencies of ϳ15%, comparable to the proteins purified in the presence of urea. In addition, in vitro translated full-length TRPV6 was retained by ATP-agarose in the absence of ATP in the binding buffer, but significantly less in the presence of ATP (data not shown).
Because mutations in individual phosphorylation sites either in the N-or in the C-terminal region (S144, T688) did not show rundown despite PMA incubation and because both fusion proteins encompassing these sites were also retained by ATP-agarose, we suggest a model where ATP directly binds to TRPV6 and might act as a stabilizing factor between the intracellular N and C termini, with residues in both the N-and C-terminal domains necessary for efficient binding in the native protein (see model, Fig. 8 ). The Hill slope of 4.8 as estimated from the dose response (Fig. 3D) strengthens this model for a tetrameric channel. Phosphorylation near the N-and C-terminal binding sites destabilizes the protein and tags channels for rundown.
DISCUSSION
Stringent regulation of Ca 2ϩ influx through TRPV6 is a necessary requirement to avoid Ca 2ϩ overload. TRPV6 is inactivated by several Ca 2ϩ -dependent pathways such as regulation by calmodulin, breakdown of PIP 2 and probably constitutive exo-and endocytotic mechanisms (38, 39) . However, there are also Ca 2ϩ -independent mechanisms that lead to channel rundown. Our work identifies ATP as an intracellular ligand that stabilizes the channel and prevents rundown. Because both absolute and normalized maximal current densities are not significantly different within the recording time with or without ATP, ATP does not seem to increase the number of channels in the membrane, although it may prevent the reduction of the number of channels that could lead to rundown. The prevention of rundown does not necessitate hydrolysis of ATP, shows nucleotide specificity (although other phosphorylated nucleotides can partially substitute), and cannot be mimicked by PIP 2 . Stabilization of current size shows an EC 50 of ϳ380 M free ATP. This value corresponds well with physiological levels of free ATP and allows the channels to respond to small decreases in ATP concentration to prevent Ca 2ϩ overload while the Ca 2ϩ -ATPases in the plasma membrane (EC 50 for ATP 0.1-1 M; see ref. 40) are still functional. We identified R153 and R154 as being essential for mediating the functional ATP effect. Disruption of this site both by mutagenesis or competition by a peptide resembling this linker sequence disables ATP from decreasing current increments and preventing rundown. Because the RR/QP mutants still show normal currents in the absence of ATP, these mutations did not disturb essential functions not related to the ATP effect. However, charge reversion at this site by creation of RR/EE mutant channels severely reduced current size, which mimics to some extent adding negative charges from ATP's phosphate moieties, but is unable to substitute the adenosine moiety of ATP, which may have its own binding site (see Figs. 3A, B and 8). Evidence from ATP-agarose pulldown experiments support a hypothesis that ATP interacts with this N-terminal ARD domain through its negatively charged phosphate groups. Because Phelps et al. (22) did not find retention of mTRPV6 ARD by ATPagarose, we also expressed and purified ARD and CT of hTRPV6 with a similar C-terminal 6xHIS tag under native conditions. ARD still showed binding to ATPagarose, indicating that species differences or storage conditions (10 mM EDTA, 2.5 mM 2-mercaptoethanol; see ref. 22 ) may account for differences in binding. The effects of ATP on both current stabilization and activa- Figure 8 . Model of regulatory mechanisms on TRPV6 by ATP and phosphorylation. To simplify graph, only one poreforming subunit is represented. In the absence of ATP, the channel is prone to both Ca 2ϩ -dependent (calmodulin) and Ca 2ϩ -independent regulation and rundown. Sufficient ATP stabilizes N and C termini and prevents channel rundown. Phosphorylation hinders ATP binding and thus reduces its stabilizing effect. tion kinetics were disrupted when TRPV6 cells (stable or transient expression) were incubated with PMA. This effect is PKC specific and requires activation of PKC ␤II , a PKC isoform that is not strongly expressed in HEK293 cells but is present together with TRPV6 in placenta. Overexpression of PKC ␤II , but not of PKC ␣, obliterates the need for PMA preincubation. The results obtained from mutating individual phosphorylation sites argue for a direct effect, where phosphorylation of TRPV6 might hinder binding of ATP. Because both the Nterminal and the distal TRPV6 C-terminal fusion proteins are retained by ATP-agarose and because mutagenesis of putative phosphorylation sites within these domains (S144A and T688A) are able to suppress the PMA effect, we propose a synergistic effect of both binding sites. ATP might form a bridge between both domains and thereby alter channel properties (Fig. 8) , leading to slowed current development and reduced rundown. To fully understand the dual effects of ATP, single-channel analyses will be necessary. Low-resolution freeze fracture data obtained for TRPV1 (41) may suggest an interaction between N-and C-terminal regions. Because a mutant that lacks the C-terminal calmodulin binding site of TRPV6 still shows an effect of ATP on rundown (data not shown), the C-terminal ATP binding site does not overlap with the calmodulin binding site, unlike the multiligand binding site of TRPV1 (21) .
A small drop in cellular-free ATP levels (i.e., by a 1-2 mM increase in Mg 2ϩ ; see ref. 42 ) leads to channels less stable and more prone to both Ca 2ϩ -dependent and Ca 2ϩ -independent rundown phenomena and thus a reduction in overall Ca 2ϩ influx. Activation of PKC ␤II prevents stabilization by ATP, and channels show more rundown and Ca 2ϩ -dependent inactivation. The upstream GPCR that activates PKC ␤II in vivo may thus be involved in feedback regulation when sufficient Ca 2ϩ has been taken up by TRPV6 and may also be responsible for conferring an allele-specific advantage. It will be interesting to analyze if and how both kinases regulate the native channels. Unfortunately, these studies are hampered by the difficulty in obtaining human cells in which native TRPV6 currents can be measured.
